A group representing Canada’s doctors says designing marijuana packaging should be left to federal officials and public health experts, not cannabis producers and distributors.
The Canadian Medical Association said product labelling is an important way to educate consumers, especially young people, about the risks of using marijuana.
The association is also urging Ottawa to apply the same standards to marijuana as it does to prescription medication and prohibit health claims that are not backed by scientific evidence.
Health Canada applies different levels of scrutiny to prescription drugs than it does to non-prescription medication, natural health products, cosmetics and medical devices – a fact the medical association says is not widely understood by Canadians.
WATCH: Plan to legalize pot by 2018 has some wondering if Canada is ready
The association, which is a voluntary group representing the majority of the country’s physicians, said consumers need to be protected from misleading health claims, and said it wants a single set of regulations in place for both the medical and recreational marijuana industry.
Canada is expected to legalize recreational marijuana this summer.
- Canadian man dies during Texas Ironman event. His widow wants answers as to why
- ‘Shock and disbelief’ after Manitoba school trustee’s Indigenous comments
- Several baby products have been recalled by Health Canada. Here’s the list
- ‘Sciatica was gone’: hospital performs robot-assisted spinal surgery in Canadian first
Comments